Biohaven Pharmaceutical Hold
13F holders, Q1 2025 (March 31)2holders
1new positions
1sold out
$24.04avg. 13F price*
At the end of Q1 2025, 2 institutions reported holding Biohaven Pharmaceutical Hold in their 13F filings, unchanged from Q4 2024. 1 opened new positions and 1 sold out. The largest holders were Knoll Capital Management, LLC ($20.0M) and FNY Investment Advisers, LLC ($19K).
- Company
- Biohaven Pharmaceutical Hold
- CUSIP
- G11196105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $19K |
| Exits | 1 | $275K |
All 13F filers, Q4 2024 → Q1 2025: 71,257 shares bought and 7,365 shares sold, net +63,892 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Knoll Capital Management, LLC | 12.99% | Add +9.3% | 830,879 | $20.0M |
| FNY Investment Advisers, LLC | 0.01% | New | 800 | $19K |
"% of holder's portfolio" is BIOHAVEN PHARMACEUTICAL HOLD's weight in each manager's 13F, not the share of Biohaven Pharmaceutical Hold the manager owns.